Skip to main navigation Skip to search Skip to main content

A Phase 3b, Open-Label, Single-Group Immunogenicity and Safety Study of Topical Recombinant Thrombin (rThrombin) in Surgical Hemostasis

Project: Research

Project Details

StatusFinished
Effective start/end date07/19/0706/11/10

Funding

  • ZymoGenetics Incorporated: $109,500.00